Last reviewed · How we verify
Dexamethasone Sodium Phosphate Injection, USP — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Dexamethasone Sodium Phosphate Injection, USP (Dexamethasone Sodium Phosphate Injection, USP) — Mercator MedSystems, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Dexamethasone Sodium Phosphate Injection, USP TARGET | Dexamethasone Sodium Phosphate Injection, USP | Mercator MedSystems, Inc. | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Dexamethasone Sodium Phosphate Injection, USP CI watch — RSS
- Dexamethasone Sodium Phosphate Injection, USP CI watch — Atom
- Dexamethasone Sodium Phosphate Injection, USP CI watch — JSON
- Dexamethasone Sodium Phosphate Injection, USP alone — RSS
Cite this brief
Drug Landscape (2026). Dexamethasone Sodium Phosphate Injection, USP — Competitive Intelligence Brief. https://druglandscape.com/ci/dexamethasone-sodium-phosphate-injection-usp. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab